# FDA recall D-0783-2026

> **ACCORD HEALTHCARE, INC.** · Class II · drug recall initiated 2026-08-06.

## Product

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17.

## Reason for recall

Subpotent Drug

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0783-2026
- **Recalling firm:** ACCORD HEALTHCARE, INC.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-08-06
- **Report date:** 2026-09-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Raleigh, NC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0783-2026

## Citation

> MORVS. FDA recall D-0783-2026. Retrieved 2026-10-23 from https://api.morvs.ai/recall/D-0783-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*